Progyny, Inc.PGNYEarnings & Financial Report
Progyny, Inc. is a leading fertility and family building benefits provider operating primarily in the United States. It partners with employers to offer benefits including in vitro fertilization, fertility preservation, adoption assistance, and surrogacy support, serving millions of members across diverse industry segments.
Revenue
$298.4M
Gross Profit
$63.4M
Operating Profit
$15.8M
Net Profit
$10.5M
Gross Margin
21.3%
Operating Margin
5.3%
Net Margin
3.5%
YoY Growth
10.6%
EPS
$0.12
Financial Flow
Progyny, Inc. Q4 2024 Financial Summary
Progyny, Inc. reported revenue of $298.4M (up 10.6% YoY) for Q4 2024, with a net profit of $10.5M (down 21.8% YoY) (3.5% margin). Cost of goods sold was $235.0M, operating expenses totaled $47.6M.
Key Financial Metrics
| Total Revenue | $298.4M |
|---|---|
| Net Profit | $10.5M |
| Gross Margin | 21.3% |
| Operating Margin | 5.3% |
| Report Period | Q4 2024 |
Revenue Breakdown
Progyny, Inc. Q4 2024 revenue of $298.4M breaks down across 2 segments, led by Fertility Benefit Services at $187.5M (62.8% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Fertility Benefit Services | $187.5M | 62.8% |
| Pharmacy Benefit Services | $111.0M | 37.2% |
Progyny, Inc. Revenue by Segment — Quarterly Trend
Progyny, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Fertility Benefit Services and Pharmacy Benefit Services) has evolved quarter over quarter.
| Segment | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Fertility Benefit Services | $208.6M | $201.9M | $213.9M | $206.4M |
| Pharmacy Benefit Services | $109.8M | $111.4M | $118.9M | $117.6M |
Progyny, Inc. Annual Revenue by Year
Progyny, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.3B).
| Year | Annual Revenue |
|---|---|
| 2025 | $1.3B |
| 2024 | $1.2B |
| 2023 | $1.1B |
| 2022 | $786.9M |
Progyny, Inc. Quarterly Revenue & Net Profit History
Progyny, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $318.4M | +6.7% | $12.5M | 3.9% |
| Q3 2025 | $313.3M | +9.3% | $13.9M | 4.4% |
| Q2 2025 | $332.9M | +9.5% | $17.1M | 5.1% |
| Q1 2025 | $324.0M | +16.5% | $15.1M | 4.6% |
| Q4 2024 | $298.4M | +10.6% | $10.5M | 3.5% |
| Q3 2024 | $286.6M | +2.0% | $10.4M | 3.6% |
| Q2 2024 | $304.1M | +8.8% | $16.5M | 5.4% |
| Q1 2024 | $278.1M | +7.6% | $16.9M | 6.1% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $278.1M | $304.1M | $286.6M | $298.4M | $324.0M | $332.9M | $313.3M | $318.4M |
| YoY Growth | 7.6% | 8.8% | 2.0% | 10.6% | 16.5% | 9.5% | 9.3% | 6.7% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $794.3M | $698.6M | $660.0M | $607.1M | $730.3M | $761.0M | $795.2M | $742.4M |
| Liabilities | $222.7M | $242.4M | $225.1M | $185.0M | $263.1M | $245.9M | $235.2M | $226.4M |
| Equity | $571.6M | $456.2M | $434.9M | $422.1M | $467.2M | $515.0M | $560.0M | $516.0M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $25.7M | $56.7M | $44.5M | $52.2M | $49.8M | $55.5M | $50.7M | $54.2M |